Literature DB >> 16000490

Intra- and interpatient variability of the hsp65 and 16S-23S intergenic gene region in Mycobacterium abscessus strains from patients with cystic fibrosis.

Brigitte König1, Ina Tammer, Veronika Sollich, Wolfgang König.   

Abstract

To establish the exact pathogenic role of Mycobacterium abscessus in cystic fibrosis (CF), molecular tests are required for accurate identification. Forty-eight M. abscessus isolates from seven patients with CF were analyzed by sequence analysis for sequence variants within the hsp65 gene and the 16S-23S intergenic sequence (ITS). We detected two different hsp65 genes and correspondingly two ITS sequevars belonging to M. abscessus type I and type II.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000490      PMCID: PMC1169134          DOI: 10.1128/JCM.43.7.3500-3503.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Rapid identification of mycobacteria to species level by PCR-restriction fragment length polymorphism analysis of the hsp65 gene and proposition of an algorithm to differentiate 34 mycobacterial species.

Authors:  A Devallois; K S Goh; N Rastogi
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

2.  Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods.

Authors:  B Springer; L Stockman; K Teschner; G D Roberts; E C Böttger
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

3.  Mycobacterium chelonae vs. abscessus.

Authors:  R J Wallace; B A Brown; D E Griffith
Journal:  Pediatr Infect Dis J       Date:  1997-08       Impact factor: 2.129

4.  Mycobacterial lung disease in cystic fibrosis: a prospective study.

Authors:  B Fauroux; B Delaisi; A Clément; C Saizou; D Moissenet; C Truffot-Pernot; G Tournier; H Vu Thien
Journal:  Pediatr Infect Dis J       Date:  1997-04       Impact factor: 2.129

Review 5.  Nontuberculous mycobacteria.

Authors:  D E Griffith
Journal:  Curr Opin Pulm Med       Date:  1997-03       Impact factor: 3.155

6.  Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies.

Authors:  F Alcaide; I Richter; C Bernasconi; B Springer; C Hagenau; R Schulze-Röbbecke; E Tortoli; R Martín; E C Böttger; A Telenti
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

7.  Nontuberculous mycobacteria in cystic fibrosis. An autopsy study.

Authors:  J F Tomashefski; R C Stern; C A Demko; C F Doershuk
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

8.  Recovery of mycobacteria from patients with cystic fibrosis.

Authors:  F C Bange; P Kirschner; E C Böttger
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

9.  hsp65 sequencing for identification of rapidly growing mycobacteria.

Authors:  H Ringuet; C Akoua-Koffi; S Honore; A Varnerot; V Vincent; P Berche; J L Gaillard; C Pierre-Audigier
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Tentative evidence of AIDS-associated biotype of Mycobacterium kansasii.

Authors:  E Tortoli; M T Simonetti; C Lacchini; V Penati; P Urbano
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

View more
  8 in total

Review 1.  An appraisal of PCR-based technology in the detection of Mycobacterium tuberculosis.

Authors:  Sathish Sankar; Mageshbabu Ramamurthy; Balaji Nandagopal; Gopalan Sridharan
Journal:  Mol Diagn Ther       Date:  2011-02-01       Impact factor: 4.074

2.  Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.

Authors:  Anne-Laure Roux; Emilie Catherinot; Fabienne Ripoll; Nathalie Soismier; Edouard Macheras; Sophie Ravilly; Gil Bellis; Marie-Anne Vibet; Evelyne Le Roux; Lydie Lemonnier; Cristina Gutierrez; Véronique Vincent; Brigitte Fauroux; Martin Rottman; Didier Guillemot; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

3.  Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii.

Authors:  Adrian M Zelazny; Jeremy M Root; Yvonne R Shea; Rhonda E Colombo; Isdore C Shamputa; Frida Stock; Sean Conlan; Steven McNulty; Barbara A Brown-Elliott; Richard J Wallace; Kenneth N Olivier; Steven M Holland; Elizabeth P Sampaio
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

4.  [Atypical mycobacteriosis of the skin caused by Mycobacterium abscessus in an immunocompetent woman].

Authors:  P Nenoff; R Uhlemann; T Grünewald; H Nenning; S Grunewald; U Paasch
Journal:  Hautarzt       Date:  2007-12       Impact factor: 0.751

5.  Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates.

Authors:  Hee-Youn Kim; Yoonwon Kook; Yeo-Jun Yun; Chan Geun Park; Nam Yong Lee; Tae Sun Shim; Bum-Joon Kim; Yoon-Hoh Kook
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

6.  Isolation and phenotypic identification of non-tuberculous mycobacteria existing in Isfahan different water samples.

Authors:  Nasr Esfahani Bahram; Sarikhani Ensieh; Moghim Shrareh; Faghri Jamshid; Fazeli Hossein; Safee Hagieh Ghasemian; Hoseini Nafiseh Sadat; Narimani Tahmineh; Sadeghi Farzaneh; Bahador Nima; Zarkesh Fatemeh
Journal:  Adv Biomed Res       Date:  2012-07-06

7.  Identification of Nontuberculous Mycobacteria Species Isolated from Water Samples Using Phenotypic and Molecular Methods and Determination of their Antibiotic Resistance Patterns by E- Test Method, in Isfahan, Iran.

Authors:  Sharareh Moghim; Ensieh Sarikhani; Bahram Nasr Esfahani; Jamshid Faghri
Journal:  Iran J Basic Med Sci       Date:  2012-09       Impact factor: 2.699

8.  Molecular Characterization of Environmental Non-Tuberculous Mycobacteria Using PCR- RFLP Analysis of 441 Bp Heat Shock Protein 65 Fragments.

Authors:  B Nasr-Esfahani; E Sarikhani; S Moghim; J Faghri; H Fazeli; N Hoseini; H Rezaei-Yazdi
Journal:  Iran J Public Health       Date:  2012-04-30       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.